About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
The Director of National Accounts team leads field based competitive defense efforts in all the key accounts assigned to their respective geographic division to ensure maintenance of market share and sales growth of BOTOX for FDA approved uses. The Director of National Accounts is accountable for developing and executing a strategy with our Payer, Contracting, Marketing, and BPS teams to focus on key accounts posing a competitive threat.
The DNA is also the lead for Allergan field-based teams in strategy development and tactical execution for all key accounts assigned to their respective geographic areas. The Director of National Accounts is accountable for developing and executing strategy and tactics with our Marketing, Reimbursement, Training and Field Leadership teams to focus on increasing interactions at all levels of the account (C Suite, Injectors, Office Managers, and Pharmacy).
1. Leads competitive threat response team for the region. Visit major threat accounts to assess risk significance. Coordinates response to all requests for price and toxin formulary reviews. Manages the execution of all buying programs within assigned region. Completes a monthly threat assessment update for management. Provides market intelligence to US and Global Marketing on competitive strategies and tactics. Presents all approved contracts to customers and monitors for adherence. Interfaces with legal department on reimportation issues. Interfaces with US marketing departments for strategic alignment.
2. Lead relevant teams in strategy development and tactical execution with academic customers. Key accounts include IDNs, Academic Medical Centers, and Headache Centers in geography. Focus is on gaining breadth and depth in each account, accessing key decision makers and the C Suite to manage BOTOX opportunities within the system. Develops and maintains a customer focus that includes effective working relationships with the clinical account specialists, sales leadership, marketing and reimbursement business advisors (RBAs). Works in conjunction with key KOL customers in conjunction to improve technical capabilities and system processes associated with BOTOX.
This position reports to the Executive Director, National Accounts U.S. Neurosciences.
Cities included: Denver, CO; Milwaukee, WI; Salt Lake City, UT; Minneapolis, MN
Qualifications
Bachelors degree in business or equivalent experience; with emphasis in management, sales or marketing preferred
Neurology and Physiatry physician specialty experience required
At least ten years successful sales experience, preferably for buy and bill injectable product(s) in a private practice and/or hospital outpatient setting, with a proven track record of successful sales performance
Acute understanding of academic health systems including roles and responsibilities of residents, fellows, chief residents, attending physicians, program directors, medical directors, department heads, administrators and relevant pharmacy personnel
Thorough comprehension of a physicians training process from MCAT to unsupervised practice
Comprehensive understanding of all Allergan/AbbVie resources relevant and useful to academic health system personnel.
People Leadership is preferred
Account / Reimbursement experience is preferred.
Academic institution experience preferred
Salesforce training experience preferred
Possess a comprehensive knowledge of the health system customer
Possess a thorough understanding of the therapeutic botulinum toxin market
Must live in specific geography of the region covered and ability to travel as needed for work requirements with approximately 50% overnight travel per month
Ability to drive a car and possess a valid and current driver's license
LI-remote
Significant Work Activities
Driving a personal auto or company car or truck, or a powered piece of material handling equipment
Travel
Yes, 5 % of the Time
Job Type
Experienced
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.